ANI 製藥公司
DE ˙ DB ˙ US00182C1036
€54.50 0.00 (0.00%)
2023-08-21
分享價格
SecurityDE:BSFA / ANI Pharmaceuticals, Inc.
InstitutionPrudential Financial Inc
Latest Disclosed Ownership19,700 shares
Latest Disclosed Value $ 1,514,930
Prudential Financial Inc reports 53.58% decrease in ownership of BSFA / ANI Pharmaceuticals, Inc.

On May 13, 2026 - Prudential Financial Inc filed a 13F-HR form disclosing ownership of 19,700 shares of ANI Pharmaceuticals, Inc. (DE:BSFA) valued at $1,514,930 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 42,440 shares of ANI Pharmaceuticals, Inc.. This represents a change in shares of -53.58% during the quarter. The current value of the position is $1,073,650 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ANI PHARMACEUTICALS COM 00182C103 19,700 -22,740 -53.58 1,515 -54.81 0.0010
2026-02-13 2025-12-31 13F ANI PHARMACEUTICALS COM 00182C103 42,440 -7,320 -14.71 3,350 -26.50 0.0040
2025-11-13 2025-09-30 13F ANI PHARMACEUTICALS COM 00182C103 49,760 31,710 175.68 4,558 287.26 0.0054
2025-08-12 2025-06-30 13F ANI PHARMACEUTICALS COM 00182C103 18,050 1,680 10.26 1,178 7.49 0.0015
2025-05-13 2025-03-31 13F ANI PHARMACEUTICALS COM 00182C103 16,370 -670 -3.93 1,096 16.37 0.0016
2025-02-11 2024-12-31 13F ANI PHARMACEUTICALS COM 00182C103 17,040 -200 -1.16 942 -8.46 0.0013
2024-11-14 2024-09-30 13F ANI PHARMACEUTICALS COM 00182C103 17,240 -1,310 -7.06 1,029 -12.96 0.0014
2024-08-13 2024-06-30 13F ANI PHARMACEUTICALS COM 00182C103 18,550 1,895 11.38 1,181 2.61 0.0018
2024-05-14 2024-03-31 13F ANI PHARMACEUTICALS COM 00182C103 16,655 -715 -4.12 1,151 20.27 0.0016
2024-02-13 2023-12-31 13F ANI PHARMACEUTICALS COM 00182C103 17,370 -25,108 -59.11 958 -61.19 0.0014
2023-11-13 2023-09-30 13F ANI PHARMACEUTICALS COM 00182C103 42,478 22,315 110.67 2,466 127.28 0.0039
2023-08-11 2023-06-30 13F ANI PHARMACEUTICALS COM 00182C103 20,163 8,270 69.54 1,085 129.87 0.0016
2023-05-12 2023-03-31 13F ANI PHARMACEUTICALS COM 00182C103 11,893 -410 -3.33 472 -4.45 0.0007
2023-02-14 2022-12-31 13F ANI PHARMACEUTICALS COM 00182C103 12,303 -150 -1.20 495 23.50 0.0008
2022-11-04 2022-09-30 13F ANI PHARMACEUTICALS COM 00182C103 12,453 -975 -7.26 400 0.50 0.0007
2022-08-15 2022-06-30 13F ANI PHARMACEUTICALS COM 00182C103 13,428 -4,110 -23.43 398 -19.27 0.0006
2022-05-13 2022-03-31 13F ANI PHARMACEUTICALS COM 00182C103 17,538 1,550 9.69 493 -33.11 0.0007
2022-02-14 2021-12-31 13F ANI PHARMACEUTICALS COM 00182C103 15,988 -10,471 -39.57 737 -15.09 0.0009
2021-11-15 2021-09-30 13F ANI PHARMACEUTICALS COM 00182C103 26,459 -15,427 -36.83 868 -40.87 0.0012
2021-08-16 2021-06-30 13F ANI PHARMACEUTICALS COM 00182C103 41,886 -26,032 -38.33 1,468 -40.20 0.0020
2021-05-12 2021-03-31 13F ANI PHARMACEUTICALS COM 00182C103 67,918 25,685 60.82 2,455 100.08 0.0037
2021-08-16 2020-12-31 13F/A-1 ANI PHARMACEUTICALS COM 0029 00182C103 42,233 30,050 246.66 1,227 256.69 0.0021
2021-02-16 2020-12-31 13F ANI PHARMACEUTICALS COM 00182C103 42,233 30,050 1,226 0.0021
2020-11-16 2020-09-30 13F ANI PHARMACEUTICALS COM 00182C103 12,183 143 1.19 344 -11.57 0.0006
2020-08-12 2020-06-30 13F ANI PHARMACEUTICALS COM 00182C103 12,040 -2,817 -18.96 389 -35.70 0.0007
2020-05-12 2020-03-31 13F ANI PHARMACEUTICALS COM 00182C103 14,857 -241 -1.60 605 -35.02 0.0013
2020-02-11 2019-12-31 13F ANI PHARMACEUTICALS COM 00182C103 15,098 -50 -0.33 931 -15.67 0.0014
2019-11-13 2019-09-30 13F ANI PHARMACEUTICALS COM 00182C103 15,148 -3,670 -19.50 1,104 -28.64 0.0018
2019-08-08 2019-06-30 13F ANI PHARMACEUTICALS COM 00182C103 18,818 81 0.43 1,547 17.11 0.0024
2019-05-15 2019-03-31 13F ANI PHARMACEUTICALS COM 00182C103 18,737 1,088 6.16 1,321 66.16 0.0022
2019-02-07 2018-12-31 13F ANI PHARMACEUTICALS COM 00182C103 17,649 -843 -4.56 795 -24.00 0.0014
2018-11-07 2018-09-30 13F ANI PHARMACEUTICALS COM 00182C103 18,492 -1,530 -7.64 1,046 -21.82 0.0015
2018-08-13 2018-06-30 13F ANI PHARMACEUTICALS COM 00182C103 20,022 3,800 23.42 1,338 41.59 0.0020
2018-05-04 2018-03-31 13F ANI PHARMACEUTICALS COM 00182C103 16,222 1,172 7.79 945 -2.58 0.0014
2018-02-13 2017-12-31 13F ANI PHARMACEUTICALS COM 00182C103 15,050 -180 -1.18 970 21.40 0.0013
2017-11-02 2017-09-30 13F ANI PHARMACEUTICALS COM 00182C103 15,230 1,280 9.18 799 22.36 0.0013
2017-08-07 2017-06-30 13F ANI PHARMACEUTICALS COM 00182C103 13,950 -130 -0.92 653 -6.31 0.0010
2017-05-10 2017-03-31 13F ANI PHARMACEUTICALS COM 00182C103 14,080 200 1.44 697 -17.12 0.0011
2017-02-07 2016-12-31 13F ANI PHARMACEUTICALS COM 00182C103 13,880 -690 -4.74 841 -13.03 0.0014
2016-11-04 2016-09-30 13F ANI PHARMACEUTICALS COM 00182C103 14,570 -4,130 -22.09 967 -7.38 0.0016
2016-08-09 2016-06-30 13F ANI PHARMACEUTICALS COM 00182C103 18,700 290 1.58 1,044 68.39 0.0018
2016-05-09 2016-03-31 13F ANI PHARMACEUTICALS COM 00182C103 18,410 400 2.22 620 -23.74 0.0011
2016-02-12 2015-12-31 13F ANI PHARMACEUTICALS COM 00182C103 18,010 -400 -2.17 813 11.83 0.0015
2015-11-10 2015-09-30 13F ANI PHARMACEUTICALS COM 00182C103 18,410 -620 -3.26 727 -38.44 0.0014
2015-08-06 2015-06-30 13F ANI PHARMACEUTICALS COM 00182C103 19,030 500 2.70 1,181 1.90 0.0021
2015-05-01 2015-03-31 13F ANI PHARMACEUTICALS COM 00182C103 18,530 18,530 1,159 0.0020
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.